.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Novartis
Federal Trade Commission
Moodys
Queensland Health
Fish and Richardson
US Department of Justice
Citi
UBS

Generated: June 23, 2017

DrugPatentWatch Database Preview

Spironolactone - Generic Drug Details

« Back to Dashboard

What are the generic sources for spironolactone and what is the scope of spironolactone freedom to operate?

Spironolactone
is the generic ingredient in two branded drugs marketed by Ivax Pharms, Sandoz, Accord Hlthcare, Mylan, Sun Pharm Inds, Amneal Pharms, Lederle, Vangard, Vintage, Gd Searle Llc, Warner Chilcott, Actavis Elizabeth, Jubilant Generics, Purepac Pharm, Upsher Smith, Superpharm, Mutual Pharm, Watson Labs, Ascot, and Orion Corp Orion, and is included in twenty-three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for spironolactone. Forty suppliers are listed for this compound.

Summary for Generic Name: spironolactone

Tradenames:2
Patents:1
Applicants:20
NDAs:23
Drug Master File Entries: see list15
Suppliers / Packagers: see list40
Bulk Api Vendors: see list45
Clinical Trials: see list156
Patent Applications: see list6,111
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:spironolactone at DailyMed

Pharmacology for Ingredient: spironolactone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purepac Pharm
SPIRONOLACTONE
spironolactone
TABLET;ORAL088053-001Aug 25, 1983DISCNNoNo► Subscribe► Subscribe
Vangard
SPIRONOLACTONE
spironolactone
TABLET;ORAL087648-001Feb 1, 1982DISCNNoNo► Subscribe► Subscribe
Gd Searle Llc
ALDACTONE
spironolactone
TABLET;ORAL012151-009Dec 30, 1983ABRXYesNo► Subscribe► Subscribe
Orion Corp Orion
SPIRONOLACTONE
spironolactone
TABLET;ORAL202187-001Mar 6, 2014ABRXNoNo► Subscribe► Subscribe
Upsher Smith
SPIRONOLACTONE
spironolactone
TABLET;ORAL087554-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Farmers Insurance
Julphar
Argus Health
Accenture
Express Scripts
McKinsey
Covington
Federal Trade Commission
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot